Announcements Trials
Browse Landscape

Status

Withdrawn 2Completed 2Unknown 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 69Breast Neoplasms 68Prostatic Neoplasms 48Lung Neoplasms 34Carcinoma, Non-Small-Cell Lung 26Colorectal Neoplasms 19Pancreatic Neoplasms 17Carcinoma, Hepatocellular 16Brain Neoplasms 15Leukemia, Myeloid, Acute 14Lymphoma 13Colonic Neoplasms 13Carcinoma, Renal Cell 13Melanoma 12Head and Neck Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Ovarian Neoplasms 11Neoplasm Metastasis 10Lymphoma, Non-Hodgkin 10Leukemia, Lymphocytic, Chronic, B-Cell 10Hematologic Neoplasms 10Uterine Cervical Neoplasms 9Liver Neoplasms 9Multiple Myeloma 8Leukemia 8Glioblastoma 8Stomach Neoplasms 7Recurrence 7Papillomavirus Infections 7Hodgkin Disease 7

Interventions

Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Observational × Hyperglycemia × Clear all
NCT03235934 2021-10-25

Glycemic Impact on Glioblastoma Outcomes

University Health Network, Toronto

Withdrawn
CNS

Glioblastoma, Hyperglycemia

NCT02372539 2021-04-26

Glucose Variability in Cancer Patients Receiving Dexamethasone

University of Colorado, Denver

Withdrawn

Hyperglycemia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡